These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 20383943

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potentiation of bortezomib-induced apoptosis by TGF-beta in cultured human Tenon's fibroblasts: contribution of the PI3K/Akt signaling pathway.
    Chung EJ, Moon SW, Jung SA, Cho YJ, Kim SW, Lee JH.
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6232-7. PubMed ID: 20702821
    [Abstract] [Full Text] [Related]

  • 6. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
    Wang H, Wang X, Li Y, Liao A, Fu B, Pan H, Liu Z, Yang W.
    Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
    [Abstract] [Full Text] [Related]

  • 7. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
    Bu R, Hussain AR, Al-Obaisi KA, Ahmed M, Uddin S, Al-Kuraya KS.
    Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells.
    Zhen YZ, Lin YJ, Liu XJ, Shang BY, Zhen YS.
    Anticancer Drugs; 2013 Jul; 24(6):609-16. PubMed ID: 23698252
    [Abstract] [Full Text] [Related]

  • 15. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.
    Tsapakidis K, Vlachostergios PJ, Voutsadakis IA, Befani CD, Patrikidou A, Hatzidaki E, Daliani DD, Moutzouris G, Liakos P, Papandreou CN.
    Int J Urol; 2012 Jun; 19(6):565-74. PubMed ID: 22324515
    [Abstract] [Full Text] [Related]

  • 16. Bortezomib as a therapeutic candidate for neuroblastoma.
    Armstrong MB, Schumacher KR, Mody R, Yanik GA, Opipari AW, Castle VP.
    J Exp Ther Oncol; 2008 Jun; 7(2):135-45. PubMed ID: 18771087
    [Abstract] [Full Text] [Related]

  • 17. [Effects of secoisolariciresinol diglucoside combined with bortezomib on induction of apoptosis in lung cancer cell line A549].
    Li XW, Yang JR.
    Zhong Yao Cai; 2012 Feb; 35(2):248-53. PubMed ID: 22822672
    [Abstract] [Full Text] [Related]

  • 18. Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B.
    Ko BS, Chang TC, Chen CH, Liu CC, Kuo CC, Hsu C, Shen YC, Shen TL, Golubovskaya VM, Chang CC, Shyue SK, Liou JY.
    Life Sci; 2010 Jan 30; 86(5-6):199-206. PubMed ID: 20006625
    [Abstract] [Full Text] [Related]

  • 19. The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway.
    Luo P, Lin M, Li L, Yang B, He Q.
    PLoS One; 2011 Jan 30; 6(11):e27298. PubMed ID: 22087283
    [Abstract] [Full Text] [Related]

  • 20. A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.
    Podar K, Gouill SL, Zhang J, Opferman JT, Zorn E, Tai YT, Hideshima T, Amiot M, Chauhan D, Harousseau JL, Anderson KC.
    Oncogene; 2008 Jan 31; 27(6):721-31. PubMed ID: 17653083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.